Ventyx Biosciences Newsroom

Ventyx Biosciences Analyst Ratings

BenzingaNov 9 00:29

LifeSci Capital Maintains Ventyx Biosciences(VTYX.US) With Buy Rating

Futu NewsNov 8 22:31

Oppenheimer Maintains Ventyx Biosciences(VTYX.US) With Buy Rating, Cuts Target Price to $9

Futu NewsNov 8 22:31

Ventyx Biosciences (VTYX) Receives a Buy From LifeSci Capital

TipRanksNov 8 21:48

H.C. Wainwright Maintains Ventyx Biosciences(VTYX.US) With Hold Rating, Maintains Target Price $6

Futu NewsNov 8 20:31

H.C. Wainwright Maintains Ventyx Biosciences(VTYX.US) With Hold Rating, Maintains Target Price $6

Futu NewsOct 16 00:31

Ventyx Biosciences' Tamuzimod: Promising Data but Insufficient for Upgrade Beyond Hold

TipRanksOct 15 23:49

Oppenheimer Maintains Ventyx Biosciences(VTYX.US) With Buy Rating, Maintains Target Price $10

Futu NewsSep 24 20:31

LifeSci Capital Maintains Ventyx Biosciences(VTYX.US) With Buy Rating

Futu NewsSep 24 10:31

LifeSci Capital Remains a Buy on Ventyx Biosciences (VTYX)

TipRanksSep 24 09:59

Ventyx Biosciences Analyst Ratings

BenzingaSep 24 01:24

HC Wainwright & Co. Reiterates Neutral on Ventyx Biosciences, Maintains $6 Price Target

BenzingaSep 24 01:24

H.C. Wainwright Maintains Ventyx Biosciences(VTYX.US) With Hold Rating, Maintains Target Price $6

Futu NewsSep 24 00:32

Wells Fargo Maintains Overweight on Ventyx Biosciences, Lowers Price Target to $11

BenzingaAug 13 01:51

Ventyx Biosciences Analyst Ratings

BenzingaAug 12 20:00

Ventyx Biosciences (VTYX) Receives a Buy From Oppenheimer

TipRanksAug 9 21:07

Ventyx Biosciences: A Buy Rating Backed by Promising Clinical Trials and Strong Financials

TipRanksAug 9 21:07

Ventyx Biosciences: A Cautious Hold Amid Intensifying Competition in Obesity Treatment Market

TipRanksAug 9 19:20

Ventyx Biosciences Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

Dow JonesJul 30 20:22

HC Wainwright & Co. Reiterates Neutral on Ventyx Biosciences, Maintains $6 Price Target

BenzingaJul 30 20:07